The Heparins. Basic and Clinical Aspects

Table of Contents

Part I. Historical Development and Properties1. Anticoagulant Heparins2. Non-anticoagulant Heparins

Part II. Clinical Applications3. Prevention of Thrombosis4. Therapy for Thrombosis

Part III. Adverse Effects5. Bleeding, heparin-induced thrombocytopenia

Authors

David Green Professor of Medicine Emeritus, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Dr. Green is a hematologist with 45 years of clinical & research experience and an expert on hemostasis and thrombosis. He teaches medical students, interns, residents, fellows, and practicing physicians and has organized symposia, given national and international presentations, and published extensively on bleeding and clotting disorders. His lectures to medical students on anticoagulant therapy have garnered teaching awards, and he has been a co-investigator on landmark clinical trials of heparin and low molecular weight heparin. He is the author or co-author of two dozen publications devoted to heparins, including 19 peer-reviewed research papers in major medical journals. He is also the author of two recent books, Linked by Blood: Hemophilia and AIDS, and Factor VIII and Von Willebrand Factor.